mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.006 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.007 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.007 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.008 |
mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.01 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.02 |